INSIGHTS ON DRUG DEVELOPMENT

• Assessing The Success Of CRISPR Gene Therapies Using ddPCR Technology

  Achieve high-fidelity results in gene therapy research. Discover how absolute quantification overcomes traditional limitations to provide the precision needed for validating CRISPR edits.

• Streamlining Early Drug Development: Efficient Synthesis Of Highly Potent Compounds

  Discover how risk‑based, phase‑appropriate synthesis enables safe, efficient production of highly potent compounds while balancing speed, worker safety, and regulatory readiness in early development.

• Scale-Up Of A Transient rAAV Production Process

  Scalable rAAV production is achievable with a transient cell line and optimized bioreactor setup, delivering high titers and reduced impurities, now validated at 200 L scale for commercial readiness.

• Step-By-Step Guide To Tech Transfer Preparation And Execution

  How does a sponsor accurately transfer detailed knowledge about its product composition, development, and current manufacturing processes to its CDMO?

• Direct Amplification Of Cell Culture Samples

  6/15/2026

  Skip extraction and move straight to amplification with a streamlined qPCR workflow. Achieve comparable performance across multiple targets while reducing costs and saving time.

• Overcoming Challenges To High-Concentration Formulation Development

  3/25/2025

  Explore how the S-HiCon™ platform optimizes high-concentration therapeutic antibody formulations, overcoming stability and manufacturability challenges to deliver safe, effective therapies.

• Organ-On-A-Chip Technology Unlocks Patient-Derived Precision Medicine

  6/25/2026

  Personalized medicine struggles with models that fail to reflect real human biology. Organ-on-a-Chip systems recreate tissue complexity, helping predict patient-specific treatment responses.

• The History Of Chemical Nomenclature And ACD/Name

  6/18/2026

  Modern chemical naming requires algorithmic precision to match evolving standards and new compound classes. Up-to-date nomenclature ensures regulatory compliance and seamless workflow integration.

• Why Biopharma Breakthroughs Aren't Moving The Market

  10/20/2025

  Biopharma is innovating fast but falling short commercially. Reveal key ecosystem gaps and five strategic actions to help strengthen resilience, accelerate performance, and futureproof organizations.